CytomX Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,803.00
64,496.00
186,711.00
181,938.00
374,110.00
436,127
Total Accounts Receivable
237.00
1,875.00
744.00
2,313.00
10,139.00
97
Other Current Assets
226.00
482.00
2,299.00
3,896.00
4,352.00
9,251
Total Current Assets
9,266.00
66,853.00
189,754.00
188,147.00
388,601.00
445,475
Net Property, Plant & Equipment
2,070.00
3,018.00
3,481.00
4,392.00
4,218.00
6,934
Total Investments and Advances
-
-
917.00
917.00
917.00
917
Long-Term Note Receivable
399.00
404.00
78.00
-
-
-
Intangible Assets
2,699.00
2,699.00
2,699.00
2,699.00
2,553.00
2,407
Other Assets
148.00
492.00
364.00
2,973.00
1,355.00
1,375
Total Assets
14,582.00
73,466.00
197,694.00
199,439.00
398,042.00
458,245
ST Debt & Current Portion LT Debt
1,258.00
1,419.00
-
-
-
Accounts Payable
930.00
1,919.00
4,697.00
6,596.00
4,205.00
Other Current Liabilities
1,984.00
7,825.00
11,042.00
29,171.00
56,942.00
Total Current Liabilities
4,172.00
11,163.00
15,739.00
35,767.00
61,147.00
Long-Term Debt
2,945.00
1,568.00
-
-
-
Deferred Taxes
491.00
499.00
507.00
513.00
-
Other Liabilities
6,136.00
61,663.00
54,901.00
84,369.00
266,601.00
Total Liabilities
13,744.00
74,893.00
71,548.00
120,960.00
328,146.00
Common Equity (Total)
43,880.00
78,137.00
126,146.00
78,479.00
69,896.00
Total Shareholders' Equity
838.00
1,427.00
126,146.00
78,479.00
69,896.00
Total Equity
838.00
1,427.00
126,146.00
78,479.00
69,896.00
Liabilities & Shareholders' Equity
14,582.00
73,466.00
197,694.00
199,439.00
398,042.00
Preferred Stock (Carrying Value)
44,718.00
76,710.00
-
-
-
About CytomX Therapeutics
View Profile
